Oct22023MHRA authorises monoclonal antibody treatment, Jemperli, to be used with chemotherapy for endometrial cancer HM Government TwitterLinkedinFacebookemailFor the first time, patients with certain types of advanced or recurrent endometrial cancer could access a treatment shown to slow its progression Follow this news feed: